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Gab1 (Grb2 associated binding protein 1) is a member of the scaffolding/docking proteins (Gab1, Gab2, and Gab3). It is required for
fibroblast cell survival and maintaining cardiac function. Very little is known about human Gab1 expression in response to chronic
hypoxia. The present study examined the hypothesis that hypoxia regulates Gab1 expression in human paediatric myocardium and
cultured rat cardiomyocytes. Here we showed that Gab1 is expressed in myocardial tissue in acyanotic and cyanotic children with
congenital heart defects. Gab1 protein was upregulated in cyanotic compared to acyanotic hearts suggesting that Gab1 upregulation
is a component of the survival program initiated by hypoxia in cyanotic children.The expression of other Gab1 interacting partners
was not affected by hypoxia and Gab1 regulation. Additionally, using an in vitromodel, we demonstrated that overexpressing Gab1
in neonatal cardiomyocytes, under hypoxic condition, resulted in the reduction of apoptosis suggesting a role for this protein in
cardiomyocyte survival. Altogether, our data provide strong evidence thatGab1 is important for heart cell survival following hypoxic
stress.
1. Introduction
Heart malformation during embryonic development can
cause congenital heart diseases (CHD).These affect one baby
in 125 live births and tetralogy of Fallot (TOF) represents
the most common form of the “blue baby syndrome.” In
UK, one baby in 3,600 is born with TOF malformation
[1]. TOF malformation exhibits four abnormalities. These
include a ventricular septal defect (VSD), right ventricular
hypertrophy, overriding of the aorta, and pulmonary stenosis
(PS) [2].The causes that induce TOF are not fully understood
but the aetiology is thought to be multifactorial. Some
studies associated TOF with untreated maternal diabetes,
phenylketonuria, and intake of retinoic acid. In addition,
chromosomal abnormalities (such as trisomies 21, 18, and 13)
have been shown to exhibit a higher TOF incidence [3]. The
degree of stenosis varies between individuals with TOF and is
the primary determinant of symptoms and severity. Indeed,
TOF is divided into two categories: acyanotic (pink) and
cyanotic (blue), depending on the blood oxygen saturation.
Although successful corrective surgery of heart defects exists,
there is an increased risk of morbidity and mortality in
cyanotic children compared with acyanotic [4]. There is
evidence that an unintended reoxygenation injury occurs
in myocardium of cyanotic patients due to the delivery of
high levels of oxygen during cardiopulmonary bypass (CPB)
used in surgery, which does not match preoperative levels of
oxygen in these children. Reoxygenation injury produces an
increase in free radical production, which may result in cell
damage [5].
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In previous study, we have shown that chronic hypoxia
in pediatric patients with TOF triggered the expression of
network of genes associated with apoptosis and reduced the
expression of genes involved in myocyte contractility and
function [6]. This state of hypoxia in TOF children may
be responsible for the susceptibility of cyanotic children to
reoxygenation injury during and after surgery. We have also
shown that concomitant with the initiation of the injurious
program a protective program is triggered by cyanosis. Gab1,
shown to significantly increase at messenger level in cyanotic
compared to acyanotic patients [6], could be an important
player in this protective program.
Grb2 associated binding protein 1 (Gab1) is a member
of the scaffolding/docking proteins (Gab1, Gab2, and Gab3)
[7, 8]. Gab1 knockout mice are not viable and display
impaired development of heart, placenta, skin, and muscle
[9]. In cultured cardiomyocytes, Gab1 is shown to interact
with tyrosine phosphatase SHP2 and to promote cardiac
hypertrophy [10]. There is evidence that Gab1 is essential
for cardiac function in the postnatal heart in vivo [11]. In
addition, Gab1 has been shown to exert an antiapoptotic role
inmouse embryonic fibroblasts and is activated through tyro-
sine phosphorylation following oxidative treatment (H
2
O
2
)
[12]. In their investigation, Holgado-Madruga and Wong
identified Gab1 as an important component in oxidative
stress signalling with an essential role in the activation of
c-Jun NH(2)-terminal kinase (JNK) and the influencing of
cell survival [12]. This Gab1 antiapoptotic role in fibroblasts
following oxidative treatment [12] has led us to hypothesise
that Gab1 may play similar role in cardiac tissue and cardiac
myocytes subjected to hypoxia.
In this study, we investigated the effects of cyanosis
on Gab1 in myocardium samples from paediatric patients
suffering from TOF and we examined the effects of hypoxia
in primary cultures of rat neonatal cardiomyocytes on Gab1
and its possible role in cell survival.
2. Materials and Methods
2.1. Reagents. All reagents were from Sigma (UK) except
those stated otherwise. Gab1 antibody was from Millipore.
Antibodies against SHP2 and p85 were from Cell Signalling
Technology (UK). GAPDH antibody was from Research
Diagnostics Inc. (UK).
2.2. Cardiac Biopsies. The collection of human right ventricle
specimens used in this study was approved by the North
Somerset and South Bristol Research Ethics Committee
(REC reference 07/H0106/172), the National Research Ethics
Service, England. Parental informed written consent was
gained for all patients. Patients with a diagnosis of cyanotic
(O
2
saturation 79.6± 7.5%; age 10.6± 5.5months) or acyanotic
(O
2
saturation 94.2 ± 3.5%; age 9.5 ± 2.3months) tetralogy of
Fallot undergoing surgical repair at the Bristol Royal Hospital
for Children were studied.
Five ventricular biopsy specimens per group were col-
lected from the right ventricle of acyanotic and cyanotic
TOF patients by using “True-Cut” needle immediately after
institution of cardiopulmonary bypass (CPB). Each specimen
was immediately put in liquid nitrogen for protein extraction.
2.3. Immunohistochemistry. Right ventricular specimens
were fixed in 4% paraformaldehyde, washed in PBS, and
embedded in paraffin and 4𝜇msectionswere obtained. Imm-
unohistochemistry was performed using the ABC-Kit from
Dakocytomation. Slides were observed with anOlympus B40
microscope. Pictures were taken using a Media Cybernetics
camera (Bethesda, MD, USA) and analysed with proimage
plus software (Bethesda, MD, USA).
2.4. RatNeonatal PrimaryCulture. All the procedures involv-
ing laboratory animals conformed to the guidelines and reg-
ulations of the University of Bristol and the United Kingdom
Home Office. Neonatal rat cardiomyocytes were cultured as
previously described with minor modifications [13, 14]. One
cell culture preparation was used for each experiment and
each experiment was repeated three times using different cell
cultures prepared at different time from pooled neonatal rat
hearts. For each cell culture, 14–24 neonatal rats were used
to harvest hearts. Hearts were quickly removed from one-
to three-day-old Wistar rats and only ventricles were kept.
They were washed with PBS three times and incubated with
0.05% trypsin and 0.02% EDTA for 30 minutes. They were
then enzymatically digested six times for fifteen minutes in
0.1% trypsin and 0.02% EDTA in PBS. Digestion was stopped
by addition of foetal calf serum at a final concentration of
30%. Cells were then centrifuged at 400 g for fiveminutes and
resuspended in DMEM supplemented with 10% FBS and 1%
P/S. Cells were then incubated one to two hours in a T75 flask
to allow noncardiac myocytes (mainly cardiac fibroblasts) to
adhere to plastic. They were then plated in gelatin-coated
plates at a density of 1.28 × 105 cells per cm2. After 40 hours
of culture, themediumwas changed inDMEMsupplemented
with 20% M-199 and 1% P/S. All treatments were performed
on three-day-old cultures. Hypoxia was induced by placing
the cells in a hypoxic chamber where oxygen levels could be
monitored (Biospherix ProOx C21, Lacona, NY, USA). The
ProOx is connected to a sensor, which monitors the oxygen
concentration within the host chamber. The ProOx quickly
infuses nitrogen (hypoxia) in the chamber and reaches a set
point. In this study, the chamber was set to 0.2% O
2
and 5%
CO
2
in a humid atmosphere for 24 hours.
2.5. Immunocytochemistry. Cells were grown on gelatin cov-
erslips (Nunc, UK) at a density of 1.32 × 105 cells per
cm2. Immunocytochemistry was performed on normoxic
and hypoxic (24 hours, 0.2% O
2
, 5% CO
2
) cells. Cells were
washed twice with PBS, fixed with 4% paraformaldehyde for
15 minutes, washed 3 times with PBS, and washed with 0.1%
Triton X-100 3 times for 5 minutes.They were then incubated
withNH
4
Cl for 10minutes, washed three times with PBS, and
blocked using 5% goat serum (Dakocytomation, Dako, UK)
for 45–60minutes at room temperature. Cells were incubated
in Gab1 overnight at 4∘C, washed three times, incubated
in anti-rabbit conjugated with Alexa-488 (Invitrogen, UK)
for 1 hour at room temperature, washed again, and incu-
bated with mouse antisarcomeric actin (Dakocytomation,
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Figure 1: Expression of Gab1 in acyanotic and cyanotic paediatric myocardium tissues. Immunohistochemical analysis of paraffin embedded
heart tissue from acyanotic and cyanotic patients using Gab1 specific antibody. Negative controls are section processed without using primary
antibody. Magnification: ×200.
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Figure 2: Gab1 protein expression in myocardium of cyanotic (CC) and acyanotic (AC) patients. Myocardium biopsies were homogenized
to isolate protein content and western blot analysis performed using Gab1, p85, SHP2, and GAPDH antibodies. All results were normalised
to GAPDH levels. Data are mean ± SEM. ∗∗𝑃 < 0.01 (𝑛 = 5).
4 BioMed Research International
DAPI
Gab1 Sarcomeric actin
Gab1/Sarcomeric actin/DAPI
Figure 3: Localization of Gab1 in cultured rat cardiomyocytes. Cells were cultured for 5 days in vitro then fixed and stained with specific
antibodies. Cardiomyocytes were stained for Gab1 (green) and sarcomeric actin (red) and then counterstained for nuclei with DAPI (blue).
Magnification: ×1200.
Dako, UK) and then with anti-mouse conjugated with Texas
Red (Vector Laboratories, UK). Cells were then mounted
in VECTASHIELD and observed with a Leica AOBS SP2
confocal microscope (MRC Cell Imaging Facility, University
of Bristol, UK), using excitation filters at 340–380 nm, 450–
490 nm, and 515–560 nm for DAPI, Alexa-488, and Texas
Red, respectively. The slides were observed on a 63x lens and
pictures were taken using the Leica software (Leica, Bucks,
UK).
2.6. Use of Adenoviruses. Adenoviruses expressing Gab1 wild
type were previously used [10, 15]. Adenovirus expressing
wild type Gab1 was referred to as Ad-Gab1-WT. Control ade-
novirus expressing Ad-𝛽-galactosidase was a kind gift from
Dr. Steve White (University of Bristol, UK). Cardiomyocytes
were infected with adenoviruses diluted in DMEM supple-
mented with 20% M199, 1% FBS, and 1% P/S for 24 hours.
Then, the medium was changed to DMEM supplemented
with 20% M199 and 1% P/S. The infected cells were then
subjected to normoxia or hypoxia for 24 hours.
2.7. Western Blotting. Five myocytes culture dishes (from the
same cell preparation) per group (normoxia versus hypoxia)
were used in the rat cell culture part. The in vitro experiment
was repeated three times using new cell preparation each
time. Total proteins were extracted from both clinical and rat
samples and quantified. For electrophoresis, protein samples
were prepared by adding 4x Laemmli buffer (0.24M Tris
pH 6.8, 6% SDS, 40% sucrose, 0.04% bromophenol blue,
and 10% 𝛽-mercaptoethanol), heated to 95∘C for 5min,
and loaded on a 8–10% SDS gel. Separated proteins were
transferred toHybond nitrocellulosemembrane (Amersham,
UK) which was subsequently blocked in 5% nonfat dry
milk/TBS-T (TBS-T; 20mM Tris pH 7.4, 1.37M NaCl, 1%
Tween) for 1 h and incubated in primary antibodies overnight
at 4∘C. Membranes were washed three times in TBS-T and
then incubated in appropriate anti-rabbit or anti-mouse
secondary antibody (Amersham,UK) for 1 h at room temper-
ature. Membranes were washed 3 times in TBS-T, antibody
bound HRP was detected using ECL (Amersham, UK), and
membranes were exposed to Hyperfilm (Amersham, UK).
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Figure 4: Gab1 protein expression in rat cardiomyocytes following 24 h of hypoxic treatment. Cells were treated with hypoxic conditions (H)
by incubating in a chamber with 5% CO
2
/0.2% O
2
or normoxia (N) by leaving cells in normal CO2 incubator. After 24 h cells were lysed and
western blot analysis performed using GAB1 (a), SHP2 (b), and p85 (c) antibodies. All results were normalized to GAPDH levels. Data are
mean ± SEM. ∗𝑃 < 0.05 (𝑛 = 5).
Protein bands were quantified using NIH Image J software.
The expression level of each protein was normalized to the
loading control, GAPDH, and then the obtained values for
experimental (cyanotic or hypoxic) were divided per control
value (acyanotic or normoxia). Representative blots were
presented in the western blotting figures.
2.8. Apoptosis Assay. Cell death was investigated with the
“in situ cell death detection” kit from Roche. Rat neona-
tal cardiomyocytes were cultured in 4-well chamber slides
(Nunc, UK) at a density of 1.5 × 105 cells per cm2. Cells
were washed twice with PBS and permeabilized for 1 hour
at room temperature with 0.1% Triton (v/v) in 0.1% sodium
citrate (v/v). They were then washed three times in PBS and
incubated with the labelled enzyme for 1 hour at 37∘C. They
were washed twice, mounted in VECTASHIELD containing
DAPI, and observed with an Olympus B40 microscope.
Apoptosis was quantified by counting apoptotic cells in 25
different fields or 400 cells. Pictures were taken using aMedia
Cybernetics camera (Bethesda, MD, USA) and analysed with
proimage plus software (Bethesda, MD, USA).
2.9. Statistical Analysis. All data were analyzed using the
software Instat 3.1 (GraphPad). Results are expressed as ±
standard error of mean (±SEM). Statistical significance was
assessed by one-way ANOVA or Student’s t-test. A value of
𝑃 < 0.05 was considered to be statistically significant.
3. Results
3.1. Gab1 Protein Is Expressed in Human Heart Sections of
Both Cyanotic and Acyanotic Congenital Heart Patients. The
analysis of fixed paediatric heart biopsy sections by immuno-
histochemistry showed expression of GAB1 in heart tissue
taken from both acyanotic and cyanotic patients undergoing
corrective surgery for congenital heart defects (Figure 1).
3.2. Gab1 Protein Expression Is Upregulated in Cyanotic
Patients Compared to Acyanotic. Western blot analysis of
proteins extracted from children myocardium biopsies
revealed a significant upregulation ofGab1 protein expression
in cyanotic patients (Figure 2(a)). Additionally, we investi-
gated the protein expression of Gab binding partners, SHP2
and the regulatory subunit of PI3K (p85). The levels of both
Gab binding partners proteins were unaffected (Figure 2(b)).
3.3. Gab1 Shows a Cytoplasmic Localization in Neonatal
Heart Cardiomyocytes. Gab1 appeared to be expressed in rat
neonatal cardiomyocytes (Figure 3). It is interesting to note
that Gab1 is locatedmainly in the cytoplasm of normoxic cells
with some nuclear expression.
3.4. Hypoxia Produce a Downregulation of GAB1 in Cultured
Rat Cardiomyocytes. As there is a limit to what can be done
using human biopsies, an in vitro model of cyanosis would
be advantageous. Both GAB1 and SHP2 were downregulated
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Figure 5: (a) Protein expression level of Gab1, p85, and SHP2 in infected rat neonatal cardiomyocytes. Cardiac myocytes were infected
with Ad-𝛽-Gal (50 MOI) and Ad-Gab1-WT (10 MOI), for 24 hours. GAPDH was used as a loading control. (b) Apoptosis quantification of
infected rat neonatal cardiomyocytes subjected to normoxia and hypoxia. Cardiac myocytes were infected with Ad-𝛽-galactosidase (Ad-𝛽-
Gal) and Ad-Gab1-WT, for 24 hours. Data are mean ± SEM. ∗𝑃 < 0.05. (c) Representative pictures of the TUNEL assay performed on rat
neonatal cardiomyocytes infected by Ad-𝛽-Gal or Ad-Gab1-WT and subjected to normoxia or hypoxia. Arrows show apoptotic nuclei (green
fluorescence). Cell nuclei were stained by DAPI (blue fluorescence). Magnification: ×400.
at the protein level following hypoxia when compared to the
normoxic control (Figures 4(a) and 4(b)). However, hypoxia
did not affect p85 protein expression (Figure 4(c)).
3.5. Gab1 Overexpression Reduces Apoptosis during Hypoxia
in Rat Cardiomyocytes. We first examined the efficiency of
cell infection by Ad-Gab1-WT (Figure 5(a)). Infection of rat
neonatal cardiomyocytes with Ad-Gab1-WT was successful
as demonstrated by the increase of Gab1 protein expression
compared to cells infected with Ad-𝛽-Gal (Figure 5(a)). In
addition, the infection with both viruses did not affect the
protein expression of p85, SHP2, and GAPDH.
During normoxia, the overexpression of Gab1 in car-
diomyocytes did not alter the percentage of apoptotic cells
significantly. However, during hypoxia Gab1 overexpression
reduced significantly apoptosis in rat neonatal cardiomy-
ocytes (Figures 5(b) and 5(c)).
4. Discussion
Our study revealed a significant upregulation of Gab1 protein
expression in cyanotic TOF patients. This result confirmed
our previous findings by microarray analysis [6]. The upreg-
ulation of Gab1 protein expression in cyanotic patients may
BioMed Research International 7
suggest an increase of survival signalling mediated through
Gab1 in cyanotic patients, independently of SHP2 and p85.
These data are the first to implicate Gab1 in cardioprotective
signalling in cyanotic patients in response to chronic hypoxia
stress.
Gab1 protein levels were downregulated during hypoxia
in neonatal rat cardiomyocytes.These are also the first results
to implicate Gab1 in the cardiomyocytes response to hypoxia.
The difference between the in vivo and in vitro data regarding
the response to hypoxia can be explained by the complexity of
the in vivo situation in comparison to the relative simplicity
of the in vitro model. Furthermore, it can be explained
by the short time of hypoxia protocol (24 h) used for rat
myocytes compared to the patients that stayed cyanotic for
months before surgery. Additionally, this may be attributed
to the difference between TOF patients’ tissue specimens and
neonatal rat ventricle. Neonatal rat ventricle includes LV and
RV tissues, whereas TOF patients’ tissue was only from RV.
It is well known that there is a difference in cardiac tissue
between the two ventricles [16].
We have previously shown that chronic hypoxia induces
both cytoprotective and injury related transcriptomic repro-
gramming [6].The protective program induces survival path-
ways and the deleterious program triggers cell death signaling
[6]. Any imbalance between these two programs would result
in either cell survival or death. Therefore, modulating the
balance between these two programs offers the potential to
develop strategies for cardioprotection.Our data suggest that,
in cyanotic pediatric heart, the increase in Gab1 expression
is part of the survival pathway. Additionally, the reduction
of apoptosis observed following the overexpression of Gab1
suggests a critical and prosurvival role for Gab1 in rat
neonatal cardiomyocytes.This is in line with previous reports
describing an antiapoptotic function for Gab1 [12]. It has also
been shown that SHP2 can help to promote cell survival by
the activation of the Raf/MEK/ERK signalling pathway [17].
Gab1 has been shown to play an antiapoptotic role in
oxidative condition [12]. It would be interesting to see how
Gab1 expression levels would be following corrective surgery
for cyanotic congenital heart disease. Similarly, it would be
interesting to examine the removal of hypoxic stress in an
experimental model. One can speculate that the removal of
hypoxic stress would result in the return of Gab1 expression
to normoxic condition levels. Additionally we would expect
thatan abrupt reoxygenation could modulate the levels of
this unique protein. Furthermore, the normal transition from
foetal to neonatal circulation may affect Gab1 expression
levels.
Gab1 expression changes following hypoxia may be con-
troversial considering the observed difference between the
in vivo and in vitro situations. However, it has previously
been shown that oxygen availability can play a critical role
in defining the cellular responses to stimuli [18]. Compared
to the cell culture system, the in vivo situation adds another
level of complexity. It is likely that other in vivo signalling
pathways come into play that could result in a different
response to hypoxia as compared to culture system. In the
above-mentioned study, it has been shown that whereas
IGF signaling promotes muscle cell differentiation under
normoxia, it stimulates proliferation under hypoxia by dif-
ferentially regulating multiple signaling pathways [18]. A
possible mechanism involved in modulating Gab1 expression
could be the HIF1 alpha-signaling pathway.
SHP2 and p85 expressions showed no difference
between cyanotic and acyanotic TOF patients; however, they
decreased, although it was not significant for p85, in hypoxic
myocytes. A plausible explanation is the difference between
RV tissue collected from TOF patients and the mixed cell
population harvested from LV and RV of neonatal rats.
There is evidence that cardiac tissue obtained from the two
ventricles has different expression profile and can respond
differently to stimuli [16].
Altogether, our data provide strong evidence that Gab1
is important for cardiomyocytes survival following hypoxic
stress. Gab1 represents a potential target for cardioprotection.
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